Malignant Solid Tumor
53
10
14
23
Key Insights
Highlights
Success Rate
70% trial completion
Published Results
12 trials with published results (23%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
18.9%
10 terminated out of 53 trials
69.7%
-16.9% vs benchmark
0%
0 trials in Phase 3/4
52%
12 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 23 completed trials
Clinical Trials (53)
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)
A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies
A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors
A Clinical Study Comparing the Bioavailability of HRS-2189 Tablets
A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors
Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy
Personalized Neoantigen-pulsed Autologous Dendritic Cell Injections for Malignant Solid Tumors
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
Clinical Evaluation of [68Ga]Ga-ELI411 PET Imaging in Adult Patients With Solid Tumors
A Phase II Clinical Study of Utidelone and Bevacizumab With or Without Etoposide in Patients With Brain Metastases From Malignant Solid Tumors
A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors.
ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu
Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CT
Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
A First-in-Human Trial of Safety and Efficacy of GEN1078 in Participants With Solid Tumors
Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors
CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)